We are live on ! Find out more
BLFS icon

BioLife Solutions
BLFS

13 hedge funds and large institutions have $736K invested in BioLife Solutions in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more funds holding

Funds holding: 10 → 13 (+3)

4% more capital invested

Capital invested by funds: $707K → $736K (+$29K)

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$7.13K
2
BFA
BlackRock Fund Advisors
California
+$3.03K
3
Morgan Stanley
Morgan Stanley
New York
+$47
4
CS
Credit Suisse
Switzerland
+$43

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Credit Suisse
Switzerland
$478K +$43 +19 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$149K – – –
BIT
3
BlackRock Institutional Trust
California
$72K – – –
PCM
4
Perkins Capital Management
Minnesota
$22K – – –
UBS Group
5
UBS Group
Switzerland
$11K +$7.13K +3,179 +179%
BFA
6
BlackRock Fund Advisors
California
$3K +$3.03K +1,349 New
CB
7
Community Bank
New York
$1K – – –
Morgan Stanley
8
Morgan Stanley
New York
– +$47 +21 New
IA
9
IFP Advisors
Florida
– +$65 +29 New

BLFS Hedge Fund Activity: Q4 2015 in Review

13 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2015, worth a combined $736K — up 4.1% from $707K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BLFS positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $7.13K.

  • 13 institutional investors held BioLife Solutions (BLFS) as of Q4 2015, up from 10 in Q3 2015.
  • Funds reported $736K of BioLife Solutions stock for Q4 2015, up 4.1% quarter-over-quarter.
  • 3 funds opened new BioLife Solutions positions in Q4 2015 and 0 closed out, a net change of +3 holders.
  • The largest BioLife Solutions buyer in Q4 2015 was UBS Group, an estimated $7.13K added.

Based on aggregated 13F filings for Q4 2015.